Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665703 | SCV000789866 | pathogenic | Fanconi anemia complementation group A | 2017-02-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000798970 | SCV000938615 | pathogenic | Fanconi anemia | 2023-12-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys846Glnfs*20) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is present in population databases (rs763378933, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Fanconi anemia (PMID: 9371798, 17924555, 21273304, 24584348, 28717661, 29098742). ClinVar contains an entry for this variant (Variation ID: 550840). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000665703 | SCV002022290 | pathogenic | Fanconi anemia complementation group A | 2019-05-20 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252201 | SCV002523161 | pathogenic | See cases | 2021-05-10 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PS4, PM2 |
Neuberg Centre For Genomic Medicine, |
RCV000665703 | SCV004048012 | pathogenic | Fanconi anemia complementation group A | criteria provided, single submitter | clinical testing | The frameshift variant c.2535_2536del (p.Cys846GlnfsTer20) in the FANCA gene has been reported previously in homozygous state in a family affected with Fanconi anemia (Kimble DC. et al., 2018). This variant is reported with the allele frequency (0.0008%) in the gnomAD and novel in 1000 genome database. It is submitted to ClinVar database as Pathogenic. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic | |
Baylor Genetics | RCV000665703 | SCV004196018 | pathogenic | Fanconi anemia complementation group A | 2024-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000665703 | SCV005644478 | pathogenic | Fanconi anemia complementation group A | 2024-02-28 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000665703 | SCV001425827 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Daniela Pilonetto, Johan de Winter. |
Natera, |
RCV000798970 | SCV002092596 | pathogenic | Fanconi anemia | 2020-07-31 | no assertion criteria provided | clinical testing |